Platinum complexes and methods of use

The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to...

Full description

Saved in:
Bibliographic Details
Main Authors Kay, Heidi, Palmer, Jay W, Stanko, Joseph A
Format Patent
LanguageEnglish
Published 21.08.2012
Online AccessGet full text

Cover

Abstract The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.
AbstractList The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.
Author Palmer, Jay W
Kay, Heidi
Stanko, Joseph A
Author_xml – sequence: 1
  givenname: Heidi
  surname: Kay
  fullname: Kay, Heidi
– sequence: 2
  givenname: Jay W
  surname: Palmer
  fullname: Palmer, Jay W
– sequence: 3
  givenname: Joseph A
  surname: Stanko
  fullname: Stanko, Joseph A
BookMark eNrjYmDJy89L5WRQDchJLMnMK81VSM7PLchJrUgtVkjMS1HITS3JyE8pVshPUygtTuVhYE1LzClO5YXS3AwKbq4hzh66pcUFiSWpeSXF8elFiSDKwMLIxNzExNSYCCUA-qkpvw
ContentType Patent
CorporateAuthor University of South Florida
CorporateAuthor_xml – name: University of South Florida
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 08247445
GroupedDBID EFH
ID FETCH-uspatents_grants_082474453
IEDL.DBID EFH
IngestDate Sun Mar 05 22:33:23 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_082474453
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8247445
ParticipantIDs uspatents_grants_08247445
PatentNumber 8247445
PublicationCentury 2000
PublicationDate 20120821
PublicationDateYYYYMMDD 2012-08-21
PublicationDate_xml – month: 08
  year: 2012
  text: 20120821
  day: 21
PublicationDecade 2010
PublicationYear 2012
References Horiguchi, A. et al. "STAT3, but Not ERKs, Mediates the IL-6-Induced Proliferation of Renal Cancer Cells, ACHN and 769P", Kidney Int, 2002, pp. 926-938, vol. 61.
Kay et al. (7977381) 20110700
Song, J. I. et al. "STAT Signaling in Head and Neck Cancer", Oncogene, 2000, pp. 2489-2495, vol. 19.
Chernyaev, I.I. et al. "Reaction of platinum(II) nitrodiamines with hydrochloric acid" Zhurnal Neorganicheskoi Khimii, 1966, 11(6):1365-1373, abstract only.
Kukushkin, Y.N. and Dkhara, S.C. "Effect of intrasphere acido groups on the redox potentials of systems consisting of platinum complexes" Zhurnal Neorganicheskoi Khimii, 1969, 14(10):2816-2819, abstract only.
Catlett-Falcone, R. et al. "STAT Proteins as Novel Targets for Cancer Therapy", Curr. Opin. Oncol., 1999, pp. 490-496, vol. 11.
Coffer, P. J. et al. "The Role of STATs in Myeloid Differentiation and Leukemia", Oncogene, 2000, pp. 2511-2522, vol. 19.
Cuny, G.D. et al. "Photoactivated Virucidal Properties of Tridentate 2,2′-Dihydroxy Azobenzene and 2-Salicylideneaminophenol Platinum Pyridine Complexes", Bioorganic & Medicinal Chemistry Letters, 1999, pp. 237-240, vol. 9.
Stewart et al. (7754684) 20100700
Palmer, J.W. et al. "Oxidation of platinum(II) mono(ethylenediamine) complexes with the oxides of nitrogen, NO and NO2; possible antitumor agents" Florida Scientist, 1995, vol. 58, No. 4, pp. 359-365.
Zheligovskaya, N.N. et al. "Platinum(IV) diamine dichloro complex conversions in solutions" Vestnik Moskovskogo Universiteta, Seriya 2: Khimiya, 1970, 11(1):32-37, abstract only.
Kay et al. (2005/0288365) 20051200
Nitiss, J. L. "A Copper Connection to the Uptake of Platinum Anticancer Drugs", Proc. Natl. Acad. Sci. USA, 2002, pp. 13963-13965, vol. 99, No. 22.
Stark, G. R. et al. "How Cells Respond to Interferons", Annu. Rev. Biochem, 1998, pp. 227-264, vol. 67.
Turkson, J. et al. "STAT Proteins: Novel Molecular Targets for Cancer Drug Discovery", Oncogene, 2000, pp. 6613-6626, vol. 19.
Yu et al. (2004/0175369) 20040900
(0812852) 19971200
Tobe et al. (3904663) 19750900
PTO English-language translation of I. I. Chernyayev, Izv. Plat., pp. 55-71, (2010).
(0 174 114) 19861200
Burdge, J.R. et al. "Oxidation of platinum (II) bis(ethylenediamine) complexes with the oxides of nitrogen, NO and NO2; a model for synthesis of platinum (IV) nitro compounds as potential antitumor agents" Florida Scientist, 1995, vol. 58, No. 3, pp. 274-285.
Turkson, J. et al. "Phosphotyrosyl Peptides Block Stat3-Mediated DNA Binding Activity, Gene Regulation, and Cell Transformation", J. Biol. Chem., 2001, pp. 45443-45455, vol. 276, No. 48.
Kukushkin, V.Y. and Tkachuk, V.M. "Reaction of platinum(ii) nitro complexes with phosphorus pentachloride" Zhurnal Neorganicheskoi Khimii, 1987, 32(12):3118-3119, abstract only.
(0328274) 19890800
(WO 2005/023824) 20050300
Wagner, B. J. et al. "The SIF Binding Element Confers sis/PDGF Inducibility Onto the c-fos Promoter", EMBO J., 1990, pp. 4477-4484, vol. 9, No. 13.
Nielsen, M. et al. "Constitutive Activation of a Slowly Migrating Isoform of Stat3 in Mycosis Fungoides: Tyrphostin AG490 Inhibits Stat3 Activation and Growth of Mycosis Fungoides Tumor Cell Lines", Proc. Natl. Acad. Sci. USA, 1997, pp. 6764-6769, vol. 94.
Imfeld et al. (2002/0035243) 20020300
Samatov et al. Izvestiya Akademii Nauk SSSR Seriya Khimicheskaya, 1974, pp. 1467-1472, No. 9, XP009041872.
Akira, S. "Roles of STAT3 Defined by Tissue-Specific Gene Targeting", Oncogene, 2000, pp. 2607-2611, vol. 19.
Yu, C. L. et al. "Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein", Science, 1995, pp. 81-83, vol. 269, No. 32.
Grandis, J. R. et al. "Constitutive Activation of Stat3 Signaling Abrogates Apoptosis in Squamous Cell Carcinogenesis In Vivo", Proc. Natl. Acad. Sci. USA, 2000, pp. 4227-4232, vol. 97, No. 8.
I. I. Chernyayev, Izv. Plat., pp. 55-71, 1931.
Gouilleux, F. et al. "Prolactin and Interleukin-2 Receptors in T Lymphocytes Signal Through a MGF-STAT5-like Transcription Factor", Endocrinology, 1995, pp. 5700-5708, vol. 136, No. 12.
Darnell, J. E., Jr. et al. "Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins", Science, 1994, pp. 1415-1421, vol. 264, No. 5164.
Kotenko, S. V. et al. "Jak-Stat Signal Transduction Pathway Through the Eyes of Cytokine Class II Receptor Complexes", Oncogene, 2000, pp. 2557-2565, vol. 19.
Bromberg, J. F. et al. "Stat3 as an Oncogene", Cell, 1999, pp. 295-303, vol. 98.
Turkson et al. (7763585) 20100700
Turkson, J. et al. "Stat3 Activation by Src Induces Specific Gene Regulation and is Required for Cell Transformation", Mol. Cell. Biol., 1998, pp. 2545-2552, vol. 18, No. 5.
Bromberg, J. F. et al. "Transcriptionally Active Stat1 is Required for the Antiproliferative Effects of Both Interferon Alpha and Interferon Gamma", Proc. Natl. Acad. Sci. USA, 1996, pp. 7673-7678, vol. 93.
Chernyaev, I.I. and Leonova, T.N. "Complexes of platinum with 2,2′-dimethylhydrazine" Zhurnal Neorganicheskoi Khimii, 1969, 14(2):591-592, abstract only.
Cernjaev, I.I. "Nitro-trichloro-verbindungen [Pt a2 Ci3 NO2] Isomerie I, II, III" Izv. Plat, 8, 1931, 55/71, 64 as quoted in Gmelin, Handbook of Inorganic Chemistry, Pt, vol. 63, Part D, pp. 558-560.
Garcia, R. et al. "Constitutive Activation of Stat3 in Fibroblasts Transformed by Diverse Oncoproteins and in Breast Carcinoma Cells", Cell Growth Diff., 1997, pp. 1267-1276, vol. 8.
Fukada, T. et al. "Two Signals are Necessary for Cell Proliferation Induced by a Cytokine Receptor gp130: Involvement of STAT3 in Anti-Apoptosis", Immunity, 1996, pp. 449-460, vol. 5.
Dickinson, W.L. and Johnson, R.C. "Mercuric ion induced hydrolysis of trans-dibromodinitroethylenediamineplatinum(IV)" Inorganic Chem., 1973, 12(9):2048-2050.
Turkson, J. et al. "Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein", Mol. Cell. Biol., 1999, pp. 7519-7528, vol. 19, No. 11.
Catlett-Falcone, R. et al. "Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells", Immunity, 1999, pp. 105-115, vol. 10.
Rudyi et al. Koordinatsionnaya Khimiya, 1975, p. 1572, vol. 1, XP009041868.
Lin, T. S. et al. "STAT Signaling in the Pathogenesis and Treatment of Leukemias", Oncogene, 2000, pp. 2496-2504, vol. 19.
Bonny (2002/0120100) 20020800
(0 193 936) 19861000
Kunisada, K. et al. "Activation of gp130 Transduces Hypertrophic Signals Via STAT3 in Cardiac Myocytes", Circulation, 1998, pp. 346-352, vol. 98.
Grandis, J. R. et al. "Requirement of Stat3 but Not Stat1 Activation for Epidermal Growth Factor Receptor-Mediated Cell Growth In Vitro", J. Clin. Invest., 1998, pp. 1385-1392, vol. 102, No. 7.
Howell, B.A. et al., "Substituted catecholato(1,2-diaminocyclohexane)-platinum(II) Compounds," Inorganica Chimica Acta, 1988, pp. 181-183, vol. 142.
Kay (2010/0190180) 20100700
Muraveiskaya et al. Zhurnal Neorganicheskoi Khimii, 1971, pp. 1643-1649, vol. 16, XP009041849.
Chernyaev, I.I. et al., "Nitrosation of amines in platinum (IV) triamines of ribbed structure," Zhurnal Neorganicheskoi Khimii, 1967, pp. 1877-1885, vol. 12, No. 7.
Kay (2009/0214626) 20090800
Samatov et al. Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1974, pp. 2142-2144, XP009041871.
Zhang, Y. et al. "Activation of Stat3 in v-Src-Transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity", J. Biol. Chem., 2000, pp. 24935-24944, vol. 275.
Grubbs et al. (5977393) 19991100
Seidel, H. M. et al. "Spacing of Palindromic Half Sites as a Determinant of Selective STAT (Signal Transducers and Activators of Transcription) DNA Binding and Transcriptional Activity", Proc. Natl. Acad. Sci. USA, 1995, pp. 3041-3045, vol. 92.
Sanchez-Perez, I. et al. "Cisplatin Induces a Persistent Activation of JNK That is Related to Cell Death", Oncogene, 1998, pp. 533-540, vol. 16.
Rosenberg et al. (4177263) 19791200
Darnell, J. E., Jr. "STATs and Gene Regulation", Science, 1997, pp. 1630-1635, vol. 277.
Hirano, T. et al. "Roles of STAT3 in Mediating the Cell Growth, Differentiation and Survival Signals Relayed Through the IL-6 Family of Cytokine Receptors", Oncogene, 2000, pp. 2548-2556, vol. 19.
Schindler, C. et al. "Transcriptional Responses to Polypeptide Ligands: The JAK-STAT Pathway", Annu. Rev. Biochem., 1995, pp. 621-651, vol. 64.
Chernyaev et al. Zhurnal Neorganicheskoi Khimii, 1966, pp. 1365-1373, vol. 11, XP009041845.
Bowman, T. et al. "STATs in Oncogenesis", Oncogene, 2000, pp. 2474-2488, vol. 19.
Palmer et al. (5849790) 19981200
Toyoizumi, T. et al. "Combined Therapy with Chemotherapeutic Agents and Herpes Simplex Virus Type 1 ICP34.5 Mutant (HSV-1716) in Human Non-Small Cell Lung Cancer", 1999, Human Gene Therapy, pp. 3013-3029, vol. 10.
Grandis, J. R. et al. "Epidermal Growth Factor Receptor-Mediated Stat3 Signaling Blocks Apoptosis in Head and Neck Cancer", Laryngoscope, 2000, pp. 868-874, vol. 110.
Bromberg, J. F. et al. "Stat3 Activation is Required for Cellular Transformation by V-src", Mol. Cell. Biol., 1998, pp. 2553-2558, vol. 18, No. 5.
Adrianova, O.N. et al., "Anomaly of the acid properties of platinum cis-dinitrotriamines of meridonal structure," Zhurnal Neorganicheskoi Khimii, 1978, pp. 2155-2158, vol. 23, No. 8.
Samatov et al., Izvestiia Akademii Nauk SSSR. Seriia Khimicheskaia, vol. 7, pp. 1467-1472, 1974.
Kortepeter, M.G. et al. "Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit" Emerging Infect. Dis., 2008, 14(6):881-887.
Garcia, R. et al. "Constitutive Activation of Stat3 by the Src and JAK Tyrosine Kinases Participates in Growth Regulation of Human Breast Carcinoma Cells", Oncogene, 2001, pp. 2499-2513, vol. 20.
Ardizzoni, A. et al. "The Combination of Etoposide and Cisplatin in Non-Small-Cell Lung Cancer (NSCLC)", Ann. Oncol., 1999, pp. S13-S17, vol. 10.
Epling-Burnette, P. K. et al. "Inhibition of STAT3 Signaling Leads to Apoptosis of Leukemic Large Granular Lymphocytes and Decreased Mcl-1 Expression",
References_xml – year: 19750900
  ident: 3904663
  contributor:
    fullname: Tobe et al.
– year: 19991100
  ident: 5977393
  contributor:
    fullname: Grubbs et al.
– year: 20100700
  ident: 7763585
  contributor:
    fullname: Turkson et al.
– year: 20020800
  ident: 2002/0120100
  contributor:
    fullname: Bonny
– year: 19861200
  ident: 0 174 114
– year: 20100700
  ident: 7754684
  contributor:
    fullname: Stewart et al.
– year: 19991200
  ident: 5998648
  contributor:
    fullname: Sohn et al.
– year: 20051200
  ident: 2005/0288365
  contributor:
    fullname: Kay et al.
– year: 19971200
  ident: 0812852
– year: 20040900
  ident: 2004/0175369
  contributor:
    fullname: Yu et al.
– year: 20100700
  ident: 2010/0190180
  contributor:
    fullname: Kay
– year: 19990700
  ident: 5922689
  contributor:
    fullname: Shaw
– year: 19890800
  ident: 0328274
– year: 19791200
  ident: 4177263
  contributor:
    fullname: Rosenberg et al.
– year: 19861000
  ident: 0 193 936
– year: 20050300
  ident: WO 2005/023824
– year: 20030200
  ident: 2003/0032594
  contributor:
    fullname: Bonny
– year: 20070700
  ident: 7238372
  contributor:
    fullname: Turkson et al.
– year: 20110700
  ident: 7977381
  contributor:
    fullname: Kay et al.
– year: 19960700
  ident: H08-176175
– year: 20050400
  ident: 2005/0074502
  contributor:
    fullname: Turkson et al.
– year: 20110900
  ident: 2011/0236471
  contributor:
    fullname: Kay et al.
– year: 20090800
  ident: 2009/0214626
  contributor:
    fullname: Kay
– year: 19981200
  ident: 5849790
  contributor:
    fullname: Palmer et al.
– year: 20020300
  ident: 2002/0035243
  contributor:
    fullname: Imfeld et al.
Score 2.863918
Snippet The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of...
SourceID uspatents
SourceType Open Access Repository
Title Platinum complexes and methods of use
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8247445
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NSwMxEB3aIqiniopVKznUY3TNZrPNWbosgrKHCr2V_Zh4sdnS7FJ_vpNdKV70msBLQpi8zORlBmCmqlgb7d8McxVwKXLBC1GGPDDka2hpytz4OOTrm0rf5csqWg0gPfyF2ZAZ8S3NxT20btvUnbiSjvd-43mf_NnnCLQ--8DeftZ5lVXmcS5kLGU0hOE88NK-RZKewjFB0JXNNu4XaSRjOMq61jMYoD2H-8zLzmy7YZ2MG7_QMXLjWV_D2bHasNbhBbBksXxO-QFz_bHzWpV18DN2eAkj8tnxCliMiowFw0gXoVRGaTRYEtejL6FSlGYCkz9hrv_pu4ETYmzhg5ri6RZGza7FKbFiU9x1S_4Gxhdsug
link.rule.ids 230,309,783,805,888,64375
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQDxOIEAbzxzgGChpmpIzrCqvqQeQdqv6cLiwdlpawc_HadHEBa6J5CSKnC-2P9sAF6oMtdEuZpgpj0uRCZ6LwueeIVtDS1NkxvkhX6YqfpOPs2A2gHiVCzMnNeIL2ou9au2iqTtyJT3v_cXzvvizqxFYueoDn9VHnZVJaa5vhQylDNZg3YWiHLlvEsU7sEVC6NNWNfYXbES7sJF0o3swwGofLhNHPKvaOeuI3PiFlpEhz_ouzpbVhrUWD4BFk9e7mK9kpu9Lx1ZJvZ_V_UMYktWOI2AhKlIX9AOd-1IZpdFgQWiProlKXpgxjP8Uc_TP3DlsJvdR-vwwfTqGbYJv4Tyc4uYEhs2yxVOCyCY_607_DUpkb7Y
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Platinum+complexes+and+methods+of+use&rft.inventor=Kay%2C+Heidi&rft.inventor=Palmer%2C+Jay+W&rft.inventor=Stanko%2C+Joseph+A&rft.number=8247445&rft.date=2012-08-21&rft.externalDBID=n%2Fa&rft.externalDocID=08247445